Toxoplasmosis laboratory findings

Jump to navigation Jump to search

Toxoplasmosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxoplasmosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxoplasmosis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxoplasmosis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxoplasmosis laboratory findings

CDC on Toxoplasmosis laboratory findings

Toxoplasmosis laboratory findings in the news

Blogs on Toxoplasmosis laboratory findings

Directions to Hospitals Treating Toxoplasmosis

Risk calculators and risk factors for Toxoplasmosis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Toxoplasma infection is diagnosed by the presence of parasite in the fluids such as blood, body fluids, or tissue by DNA amplification, microscopy or by isolation of the organism. The most commonly used diagnostic test is the PCR of the amniotic fluid and a positive test is diagnostic of congenital toxoplasmosis. The most commonly used diagnostic investigation for early detection is the serological detection of antibodies (IgG, IgM and IgA) in the serum. A combination of all the antibodies (IgG, IgM, IgA) is usally employed.[1]

Laboratory Findings

Toxoplasma infection is diagnosed by the presence of parasite in the fluids such as blood, body fluids, or tissue by DNA amplification, microscopy or by isolation of the organism. The most commonly used diagnostic test is the PCR of the amniotic fluid and a positive test is diagnostic of congenital toxoplasmosis.The most commonly used diagnostic investigation for early detection is the serological detection of antibodies (IgG, IgM and IgA) in the serum. A combination of all the antibodies (IgG, IgM, IgA) is usally employed.[1]

Principles and various methods used for the diagnosis of toxoplasmosis:

Principle Detection Method Findings supporting the diagnosis of Toxoplasmosis
Toxoplasma specific humoral responses[2] IgG, IgM, IgA Dye test, ELISA, ELISA-like assays, immunofluorescence, agglutination
  • Positive IgM after 5 days of life and in the absence of blood transfusions
  • Positive IgA after 10 days of life
  • Persistence of Toxoplasma IgG beyond 1 year of age
IgG, IgM, and IgA to specific Toxoplasma antigen

Western blot

  • Presence of specific bands only seen in the newborn or bands with higher intensity than maternal ones for IgG and/or IgM and/or IgA in a reference laboratory
Toxoplasma nucleic acid amplification DNA PCR
Immunohistochemistry of Toxoplasma specific antigens in tissue Antigens Immunoperoxidase
  • Positive result in any tissue(e.g., brain or other fetal tissue)
Visualization by microscopy Visual identification of tachyzoites and/or cysts Stains such as hematoxylin/eosin, Giemsa
  • Positive identification in a reference laboratory
Isolation of Toxoplasma Whole live parasite Inoculation in peritoneal cavity of mice
  • Detection of live cysts from any body fluid or tissue that has been inoculated in mice in a reference laboratory
  • A major problem with Toxoplasma-specific IgM testing is lack of specificity.
  • Two situations occur frequently: i) persons with a positive IgM but negative IgG, and ii) individuals with positive IgG and IgM results.
  • In the first situation, a positive IgM result with a negative IgG result in the same specimen should be viewed with great suspicion; the patient's blood should be redrawn two weeks after the first and tested together with the first specimen.
  • If the first specimen was drawn very early after infection, the patient should have highly positive IgG and IgM antibodies in the second sample.
  • If the IgG is negative and the IgM is positive in both specimens, the IgM result should be considered to be a false positive and the patient should be considered to be not infected.
  • In the second situation, a second specimen should be drawn and both specimens submitted together to a reference lab which employs a different IgM testing system for confirmation.
  • Prior to initiation of patient management for acute toxoplasmosis, all IgG/IgM positives should be submitted to a reference lab for IgG avidity testing.

Microscopy

A: Toxoplasma gondii tachyzoites, stained with Giemsa, from a smear of peritoneal fluid obtained from a mouse inoculated with T. gondii. Tachyzoites are typically crescent shaped with a prominent, centrally placed nucleus.

Toxoplasma gondii tachyzoites, stained with Giemsa
Toxoplasma gondii tachyzoites, stained with Giemsa


B: Toxoplasma gondii cyst in brain tissue stained with hematoxylin and eosin (100×). C: Zoom of Image B, T. gondii cyst.

Toxoplasma gondii cyst, hematoxylin and eosin stain
Toxoplasma gondii cyst, hematoxylin and eosin stain


Congenital Toxoplasmosis

  • If the patient is pregnant, and IgG/IgM positive, an IgG avidity test should be performed.
  • A high avidity result in the first 12 to 16 weeks of pregnancy (time dependent upon the commercial test kit) essentially rules out an infection acquired during gestation.
  • A low IgG avidity result should not be interpreted as indicating recent infection because some individuals have persistent low IgG avidity for many months after infection.
  • Suspected recent infection in a pregnant woman should be confirmed prior to intervention by having samples tested at a toxoplasmosis reference laboratory.
  • If the patient has clinical illness compatible with toxoplasmosis but the IgG titer is low, a follow-up titer two to three weeks later should show an increase in antibody titer if the illness is due to acute toxoplasmosis, assuming the host is not severely immunocompromised.

References

  1. 1.0 1.1 Foulon W, Pinon JM, Stray-Pedersen B, Pollak A, Lappalainen M, Decoster A; et al. (1999). "Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters". Am J Obstet Gynecol. 181 (4): 843–7. PMID 10521739.
  2. Tanimura K, Nishikawa A, Tairaku S, Shinozaki N, Deguchi M, Morizane M; et al. (2015). "The IgG avidity value for the prediction of Toxoplasma gondii infection in the amniotic fluid". J Infect Chemother. 21 (9): 668–71. doi:10.1016/j.jiac.2015.05.013. PMID 26141811.


Template:WikiDoc Sources